1
2
Donken, R., King, A. J., Bogaards, J. A., Woestenberg, P. J., Meijer, C. J. L. M., de Melker, H. E.
Veröffentlicht in: Donken , R , King , A J , Bogaards , J A , Woestenberg , P J , Meijer , C J L M & de Melker , H E 2018 , ' High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years after Vaccination in Young Dutch Women ' , Journal of Infectious Diseases , vol. 217 , no. 10 , pp. 1579-1589 . https://doi.org/10.1093/infdis/jiy067;
2018
Veröffentlicht in: Donken , R , King , A J , Bogaards , J A , Woestenberg , P J , Meijer , C J L M & de Melker , H E 2018 , ' High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years after Vaccination in Young Dutch Women ' , Journal of Infectious Diseases , vol. 217 , no. 10 , pp. 1579-1589 . https://doi.org/10.1093/infdis/jiy067;
2018
3
4
Woestenberg, P.J., Morel, A.E.G., Bogaards, J.A., Hooiveld, M., Schurink-van't Klooster, T.M., Hoebe, C.J.P.A., van der Sande, M.A.B., van Benthem, B.H.B.
Veröffentlicht in: Woestenberg , P J , Morel , A E G , Bogaards , J A , Hooiveld , M , Schurink-van't Klooster , T M , Hoebe , C J P A , van der Sande , M A B & van Benthem , B H B 2021 , ' Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients ' , Clinical Infectious Diseases , vol. 73 , no. 2 , pp. 291-297 . https://doi.org/10.1093/cid/ciaa582;
2021
Veröffentlicht in: Woestenberg , P J , Morel , A E G , Bogaards , J A , Hooiveld , M , Schurink-van't Klooster , T M , Hoebe , C J P A , van der Sande , M A B & van Benthem , B H B 2021 , ' Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients ' , Clinical Infectious Diseases , vol. 73 , no. 2 , pp. 291-297 . https://doi.org/10.1093/cid/ciaa582;
2021
5
Hoes, J., Woestenberg, P.J., Bogaards, J.A., King, A.J., de Melker, H.E., Berkhof, J., Hoebe, C.J.P.A., van der Sande, M.A.B., van Benthem, B.H.B.
Veröffentlicht in: Hoes , J , Woestenberg , P J , Bogaards , J A , King , A J , de Melker , H E , Berkhof , J , Hoebe , C J P A , van der Sande , M A B , van Benthem , B H B & Medical Microbiological Laboratories and Public Health Services 2021 , ' Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects ' , Clinical Infectious Diseases , vol. 72 , no. 5 , pp. E103-E111 . https://doi.org/10.1093/cid/ciaa1770;
2021
Veröffentlicht in: Hoes , J , Woestenberg , P J , Bogaards , J A , King , A J , de Melker , H E , Berkhof , J , Hoebe , C J P A , van der Sande , M A B , van Benthem , B H B & Medical Microbiological Laboratories and Public Health Services 2021 , ' Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects ' , Clinical Infectious Diseases , vol. 72 , no. 5 , pp. E103-E111 . https://doi.org/10.1093/cid/ciaa1770;
2021